Historical Stock Price
ETFs Holding RARE »    RARE Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
06/16/2021 $99.52 $99.93 $95.76 $97.78 336.80K
06/17/2021 $96.97 $97.20 $93.61 $95.98 653.20K
06/18/2021 $94.52 $95.42 $92.91 $94.92 813.50K
06/21/2021 $94.96 $96.77 $93.56 $95.49 993.50K
06/22/2021 $94.95 $96.23 $92.20 $94.77 519.60K
Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co.'s product categories are: biologics, which include Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and Mepsevii® (vestronidase alfa) for the treatment of Mucopolysaccharidosis VII; small molecules, which includes UX007 for the treatment of long-chain fatty acid oxidation disorders; and gene therapy, which includes DTX301 for the treatment of patients with ornithine transcarbamylase deficiency and DTX401 for the treatment of patients with glycogen storage disease type Ia.
RARE historical stock prices picture
Ultragenyx Pharmaceutical (RARE) has the following price history information. Looking back at RARE historical stock prices for the last five trading days, on June 16, 2021, RARE opened at $99.52, traded as high as $99.93 and as low as $95.76, and closed at $97.78. Trading volume was a total of 336.80K shares. On June 17, 2021, RARE opened at $96.97, traded as high as $97.20 and as low as $93.61, and closed at $95.98. Trading volume was a total of 653.20K shares. On June 18, 2021, RARE opened at $94.52, traded as high as $95.42 and as low as $92.91, and closed at $94.92. Trading volume was a total of 813.50K shares. On June 21, 2021, RARE opened at $94.96, traded as high as $96.77 and as low as $93.56, and closed at $95.49. Trading volume was a total of 993.50K shares. On June 22, 2021, RARE opened at $94.95, traded as high as $96.23 and as low as $92.20, and closed at $94.77. Trading volume was a total of 519.60K shares.

RARE Historical Stock Prices By Date:

RARE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ultragenyx Pharmaceutical shares, starting with a $10,000 purchase of RARE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/31/2014
End date: 06/22/2021
Start price/share: $42.25
End price/share: $94.77
Dividends collected/share: $0.00
Total return: 124.31%
Average Annual Total Return: 11.55%
Starting investment: $10,000.00
Ending investment: $22,432.86
Years: 7.39
Date Close
06/16/2021$97.78
06/17/2021$95.98
06/18/2021$94.92
06/21/2021$95.49
06/22/2021$94.77
RARE is categorized under the Healthcare sector; below are some other companies in the same sector:

RARX Historical Stock Prices
RCKT Historical Stock Prices
RCPI Historical Stock Prices
RCPT Historical Stock Prices
RDHL Historical Stock Prices
RDNT Historical Stock Prices
RDUS Historical Stock Prices
RDY Historical Stock Prices
REGN Historical Stock Prices
REPH Historical Stock Prices

Also explore: RARE shares outstanding history

RARE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.